- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms in New Zealand
Total 16887 results
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Momotaro-Gene Inc.Icahn School of Medicine at Mount SinaiWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
SanofiCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedProstate Cancer | Precancerous/Nonmalignant ConditionUnited States
-
St George Hospital, AustraliaRecruiting
-
University of Texas Southwestern Medical CenterCompletedStereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal SpacerProstate CancerUnited States
-
Royal North Shore HospitalUniversity of SydneyCompleted
-
Precision Biopsy, Inc.Suspended
-
Precision Biopsy, Inc.UnknownProstate CancerUnited States
-
Stony Brook UniversityProgenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Royal North Shore HospitalCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompleted
-
Department of Veterans Affairs, New JerseyPfizerUnknownA Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerProstate CancerUnited States
-
Department of Veterans Affairs, New JerseySanofi; PfizerUnknownProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseCompletedCastration Resistant Metastatic Prostate CancerUnited States
-
Columbia UniversityJanssen PharmaceuticalsRecruitingRecurrent Prostate CancerUnited States
-
GP-PharmTerminatedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedMetastatic Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; University of Colorado, Denver; Northwell HealthTerminatedProstate CancerUnited States
-
Yale UniversityCompleted
-
NYU Langone HealthTerminatedProstate CancerUnited States
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
New York Prostate InstituteSanofiUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMRI | Prostate CancerUnited States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of North Carolina; New York-Presbyterian Hospital Cornell Medical...CompletedPain | Metastatic Prostate CancerUnited States
-
Northwell HealthAmerican Cancer Society, Inc.CompletedProstate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedProstate CancerUnited States
-
Northwell HealthCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingStage II Prostate Adenocarcinoma | Stage III Prostate AdenocarcinomaUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
US Oncology ResearchPfizerCompleted
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Royal North Shore HospitalWithdrawn
-
BioProtectCompletedProstate CancerUnited States